{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:40:30Z","timestamp":1787240430316,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ygyno.2023.06.020","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T14:49:19Z","timestamp":1688482159000},"page":"10-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Simultaneous integrated or sequential boost to clinically involved lymph nodes in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy"],"prefix":"10.1016","volume":"176","author":[{"given":"Alper","family":"Kahvecioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi","family":"Gurlek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazli Yagiz","family":"Yedekci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezin Yuce","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melis","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferah","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2023.06.020_bb0005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.semradonc.2018.11.002","article-title":"Management of Nodal Disease in advanced cervical Cancer","volume":"29","author":"Jurgenliemk-Schulz","year":"2019","journal-title":"Semin. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.020_bb0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.020_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13014-021-01818-1","article-title":"High dose simultaneous integrated boost for node positive cervical cancer","volume":"16","author":"Jayatilakebanda","year":"2021","journal-title":"Radiat. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.020_bb0020","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.7150\/jca.29301","article-title":"Efficacy and toxicity of IMRT-based simultaneous integrated boost for the definitive Management of Positive Lymph Nodes in patients with cervical Cancer","volume":"10","author":"Dang","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.ygyno.2023.06.020_bb0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1748-717X-9-83","article-title":"IMRT with (1)(8)FDG-PET\\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer","volume":"9","author":"Cihoric","year":"2014","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.ygyno.2023.06.020_bb0030","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"Potter","year":"2018","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.020_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"Potter","year":"2006","journal-title":"Radiother. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.020_bb0040","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.020_bb0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from Gynaecological (GYN) GEC-ESTRO working group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2023.06.020_bb0050","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.22.01096","article-title":"Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study","volume":"41","author":"Schmid","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.020_bb0055","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ygyno.2020.08.021","article-title":"[(18)F]FDG-PET or PET\/CT in the evaluation of pelvic and Para-aortic lymph nodes in patients with locally advanced cervical cancer: a systematic review of the literature","volume":"159","author":"Adam","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2023.06.020_bb0060","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1136\/ijgc-2020-001973","article-title":"Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study","volume":"30","author":"Marnitz","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.020_bb0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0090-8258(03)00064-7","article-title":"Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer","volume":"89","author":"Lai","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.06.020_bb0070","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/IGC.0000000000001216","article-title":"The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer","volume":"28","author":"Cibula","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.020_bb0075","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ijrobp.2014.08.013","article-title":"Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography\/computed tomography era","volume":"90","author":"Vargo","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.ygyno.2023.06.020_bb0080","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jrr\/rrs138","article-title":"External beam boost irradiation for clinically positive pelvic nodes in patients with uterine cervical cancer","volume":"54","author":"Ariga","year":"2013","journal-title":"J. Radiat. Res."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.020_bb0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ygyno.2017.12.028","article-title":"Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer","volume":"148","author":"Bacorro","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.020_bb0090","first-page":"201","article-title":"Weekly cisplatin 20 mg\/m2 in patients with carcinoma of cervix receiving pelvic radiotherapy at Srinagarind hospital: a randomized controlled trial","volume":"11","author":"Punushapai","year":"2010","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.020_bb0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02493277","article-title":"Chemoradiation therapy for cervical cancer: toxicity of concurrent weekly cisplatin","volume":"24","author":"Ikushima","year":"2006","journal-title":"Radiat. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2023.06.020_bb0100","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/IGC.0000000000001009","article-title":"Cervical adenocarcinoma has a poorer prognosis and a higher propensity for distant recurrence than squamous cell carcinoma","volume":"27","author":"Jung","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.020_bb0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1102\/1470-7330.2008.0022","article-title":"The prognostic value of PET and PET\/CT in cervical cancer","volume":"8","author":"Grigsby","year":"2008","journal-title":"Cancer Imaging"},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.020_bb0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ygyno.2005.10.005","article-title":"F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy","volume":"101","author":"Xue","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2023.06.020_bb0115","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/IGC.0b013e3182989483","article-title":"Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy","volume":"23","author":"Onal","year":"2013","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823003785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823003785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:02:36Z","timestamp":1758772956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823003785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":23,"alternative-id":["S0090825823003785"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.06.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous integrated or sequential boost to clinically involved lymph nodes in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}